News

The contribution of next generation sequencing to epilepsy genetics.

More

Amplexa is proud to have received full accreditation of all our NGS-services effective December 3rd, 2015.

More

Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation.

More

Amplexa sponsored, exhibited and presented at the second annual NGS 2015 Nordic Conference held in the Medicon Village in Lund. Thank you for visited our booth to learn more about us and our services, and for taking the time to talk to us. Dr Klaus Brusgaard, Amplexa co-founder, gave an oral presentation on the clinical utility of our epilepsy panel highlighting what we have learned from more the most recent (300) epilepsy cases.

More

Amplexa sponsored and exhibited the Brittish Chapter ILAE Annual Scientific Meeting held at the Institute of Education in London, UK, on September 23rd to 25th. Thank you for visited our booth to learn more about us and our services, and for taking the time to talk to us.

More

Amplexa sponsored, exhibited and presented at the 31st International Epilepsy Congress held in Istanbul, Turkey on the 5th–9th of September 2015. Thank you for visited our booth to learn more about us and our services, and for taking the time to talk to us. Amplexa presented two posters at the IEC: "Targeted next generation sequencing as a diagnostic tool in 300 patients with epileptic encephelopaties" by Hans Atli Dahl et al. and "Genetic testing in adults with intellectual disability and epilepsy" by Line H.G. Larsen et al.

More

Our Childhood Epilepsy now includes 85 genes. The 7 genes added are clinically relevant, high impact genes, which add to the diagnostic value of our Childhood Epilepsy Panel. Read more about the panel in our Neurology Section and the references to research in our Publications.

More

Amplexa exhibited and sponsored the 38th National Italian Epilepsy Congress [LICE] togethter with CORI GROUP Srl. Amplexa was also invited to give an oral presentation on the benefits of genetic testing as a tool for differential diagnosis in epilepsy.

More

Mutations in KCNT1 cause a spectrum of focal epilepsies

More

Our Childhood Epilepsy now includes 78 genes. The 33 genes added are clinicallay relevant, high impact genes, which add to the diagnostic value of our Childhood Epilepsy Panel. You can read more about the panel in our Neurology Section and the references to research in our Publications.

More

Clinical Phenotype of De Novo GNAO1 Mutation: Case Report and Review of Literature

More

Amplexa exhibited at the 5th London-Innsbruck Colloquium on Status Epilepticus held at Imperial College, London (UK) to showcase Amplexa's competencies in the field of epilepsy.

More

Amplexa joined the 1st Workshop on Sleep and Epilepsy in Children Bologna (Italy) to share with the Italien epileptologist community information about our tests and competencies. Amplexa particpated together with CORI GROUP srl.

More